Literature DB >> 35065782

The COVID-19 response in Hong Kong.

Tong B Tang1.   

Abstract

Entities:  

Mesh:

Year:  2022        PMID: 35065782      PMCID: PMC8776316          DOI: 10.1016/S0140-6736(20)32217-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
Richard Horton and the Editors have repeatedly called for closer collaborations in global health. China has been taking decisive, albeit difficult, measures to prevent and manage outbreaks in diverse settings, from city epicentres to rural clusters. Although these policies might be draconian, they resulted in community solidarity and success; with one prerequisite to both solidarity and success being transparency embraced by both the government and the health profession. For example, the Zhejiang University Affiliated Hospital issued handbooks about COVID-19 prevention and treatment. These free, online, multilingual books cover topics from the construction and operation of a Fangcang shelter to the management of mental health. The earnestness of this university hospital to help supersedes intellectual property restrictions or fears of scrutiny and criticisms. It might be useful to examine whether the Chinese intervention model transcended political structure. Between January and November, 2020, Macau had merely 46 local cases and no deaths. Most cases were recorded by April 7, 2020, with a single additional case on June 26, 2020. Hong Kong had its first case in late January, 2020, followed by a second wave that peaked with 82 new cases on March 29, 2020, but petered out by late April, 2020. On July 9, 2020, daily cases jumped to 42, and rose more or less monotonically to 149 daily cases on July 30, 2020, which marked the peak of the third wave. July 1, 2020, was the anniversary of the return of sovereignty and commencement of the National Security Law, when activists disregarded physical distancing and challenged the 50-people limit in any public gathering—a limit that was relaxed in June, 2020, probably prematurely. Of course, correlation is no proof of causation. China pledged US$2 billion and vaccines for global public good. China's Ad5-vectored COVID-19 vaccine has been approved for use in the military after accelerated phase 3 trials. BBIBP-CorV, which contains inactivated SARS-CoV-2, is an equally promising vaccine candidate. When it comes to public health interventions, Hong Kong leans more towards libertarianism than collectivism, with lock-down measures similar to most European countries. Nevertheless, the Hong Kong Government ran a voluntary test programme in the first fortnight of September, 2020; as of Sept 12, 2020, 1·73 million of 7·50 million residents had been screened, and 36 asymtomatic carriers were identified, despite attempted sabotage of the tests by dissidents.7, 8 About a third of the carriers had cycle threshold values above 35, suggesting spontaneous recoveries, whereas another third had cycle thresholds of 29 or less, indicative of infectivity. To assist with the programme Chinese media reported that more than 570 clinicians came from neighbouring provinces and worked 12 h shifts, sometimes allegedly wearing adult diapers and eating only one full meal a day to meet demands. This work was inspired by the Chinese experience. More than half of Beijing's 23 million people were tested, with a focus on workers in high-risk occupations, followed by a comprehensive assessment of residents in specific districts with new cases. Beijing has had daily new cases in the low tens since Aug 5, 2020. In adopting similar though less severe measures like compulsory testing and buildings lockdown, Hong Kong has also maintained low cases, suggesting that the Chinese intervention model transcends political structure. I declare no competing interests.
  5 in total

Review 1.  A Systematic Review of the Clinical Utility of Cycle Threshold Values in the Context of COVID-19.

Authors:  Sonia N Rao; Davide Manissero; Victoria R Steele; Josep Pareja
Journal:  Infect Dis Ther       Date:  2020-07-28

2.  Offline: COVID-19 and the dangers of Sinophobia.

Authors:  Richard Horton
Journal:  Lancet       Date:  2020-07-18       Impact factor: 79.321

3.  Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial.

Authors:  Shengli Xia; Yuntao Zhang; Yanxia Wang; Hui Wang; Yunkai Yang; George Fu Gao; Wenjie Tan; Guizhen Wu; Miao Xu; Zhiyong Lou; Weijin Huang; Wenbo Xu; Baoying Huang; Huijuan Wang; Wei Wang; Wei Zhang; Na Li; Zhiqiang Xie; Ling Ding; Wangyang You; Yuxiu Zhao; Xuqin Yang; Yang Liu; Qian Wang; Lili Huang; Yongli Yang; Guangxue Xu; Bojian Luo; Wenling Wang; Peipei Liu; Wanshen Guo; Xiaoming Yang
Journal:  Lancet Infect Dis       Date:  2020-10-15       Impact factor: 25.071

4.  COVID-19 and China: lessons and the way forward.

Authors:  The Lancet
Journal:  Lancet       Date:  2020-07-25       Impact factor: 79.321

5.  Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial.

Authors:  Feng-Cai Zhu; Xu-Hua Guan; Yu-Hua Li; Jian-Ying Huang; Tao Jiang; Li-Hua Hou; Jing-Xin Li; Bei-Fang Yang; Ling Wang; Wen-Juan Wang; Shi-Po Wu; Zhao Wang; Xiao-Hong Wu; Jun-Jie Xu; Zhe Zhang; Si-Yue Jia; Bu-Sen Wang; Yi Hu; Jing-Jing Liu; Jun Zhang; Xiao-Ai Qian; Qiong Li; Hong-Xing Pan; Hu-Dachuan Jiang; Peng Deng; Jin-Bo Gou; Xue-Wen Wang; Xing-Huan Wang; Wei Chen
Journal:  Lancet       Date:  2020-07-20       Impact factor: 202.731

  5 in total
  1 in total

1.  Comprehensive Analysis of the COVID-19: Based on the Social-Related Indexes From NUMBEO.

Authors:  Xuecan Guo; Ruiyu Chai; Yan Yao; Yanbiao Mi; Yingshuang Wang; Tianyu Feng; Junwei Tian; Bocheng Shi; Jiwei Jia; Siyu Liu
Journal:  Front Public Health       Date:  2022-04-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.